A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma

• Status: Completed
• Trial end date: 2008-04-01

Summary

This study will evaluate the dose response relationship among four doses of indacaterol as well as placebo delivered via the TWISTHALER® device.

• Phase: Phase 2

Details

• Lead Sponsor: Novartis Pharmaceuticals
• Collaborator: Schering-Plough
• Treatments: Albuterol; Formoterol Fumarate